A new study shows that many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease. This real-life' view of the HCV patient care continuum in a major U.S. urban area highlights the importance of generating awareness among clinicians and at-risk groups about appropriate HCV testing, referral, support and care.
19 December 2014 | Eurekalert Inf Dis
Mention gender inequality in AIDS and the fact that more women than men live with HIV pops up. But another, rarely spoken about gendered difference is proving lethal to men with HIV. Research reveals that, across Africa, men have lower rates of HIV testing, enrollment on antiretroviral treatment, adherence, viral load suppression and survival, than women.
15 December 2014 | Inter Press Service
The Birmingham Heartlands HIV Service may be under threat as a result of the potential loss of our Sexual Health & GUM service. We need your help!
12 December 2014 | Birmingham Heartlands HIV Service
Gilead has been selling a twelve week regimen of Sovaldi in the United States for approximately $84,000, or $1,000 per pill. This is significantly more than the original price projection for Sovaldi, and in sharp contrast to the prices at which the drug is being made available in other countries. Gilead recently announced its intention to make Sovaldi available in 91 developing countries at deeply discounted prices, and the drug is reportedly available in Egypt for 99% below the U.S. price. This obvious pricing paradox is under investigation by the Senate Finance Committee, which has questioned if the market for Sovaldi “is working efficiently and rationally,” and whether “payors of health care….can carry such a load.”
12 December 2014 | Chimicles & Tikellis press release
San Francisco is already making progress when it comes to HIV prevention, treatment and retention. In 2006, San Francisco had 517 new HIV cases; by 2013, that number dropped to 359, a 30 percent decrease. The number of deaths almost halved between 2006 and 2013, going from 327 to 182. Additionally, compared to the United States, San Francisco is faring better in multiple aspects of the HIV care continuum: in 2012, 82 percent of HIV positive individuals in the U.S. were aware of their status; in San Francisco, that number was 94 percent.
11 December 2014 | Huffington Post
Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1.
10 December 2014 | Science Daily
Last year saw the lowest level of funding from charitable donors since 2007, the year when government spending on HIV began to drop. While the report notes that philanthropic support accounted for just three percent of all international funding for HIV-related efforts in low and middle-income countries, it has increasingly been cited in recent years as a source of support to fill gaps left by constricting national budgets.
10 December 2014 | Science Speaks
Myanmar has pledged to provide free treatment to around half of the country’s patients affected by HIV and AIDS by 2016, as civil society groups called on the government to increase efforts to meet upcoming global eradication targets on World AIDS Day.
05 December 2014 | Radio Free Asia
Knowing your status is the key to ending the Aids pandemic but still too few South Africans take the step to get tested for HIV. A report in the Mail & Guardian this week less than a third of the country's 35-million sexually active people get tested for HIV annually.
03 December 2014 | AllAfrica.com
The CDC has reframed the HIV treatment cascade figures to highlight the various reasons why only 30 percent of Americans have a fully suppressed virus.
03 December 2014 | POZ